Receptor mechanisms involved in the 5-HT-induced inotropic action in the rat isolated atrium

British Journal of Pharmacology

Volumn 123, Issue 6, 1998, Pages 1182-1188

  Läer, Stephanie ^a   Remmers, Freerk ^a   Scholz, Hasso ^a   Stein, Birgitt ^a   Müller, Frank Ulrich ^b   Neumann, Joachim ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

5 HT receptors; GR 125487; Inotropy; Ketanserin; SB 203186

Indexed keywords

3 INDOLECARBOXYLIC ACID 2 (1 PIPERIDINYL)ETHYL ESTER; 5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; CYCLIC AMP; INOSITOL 1,4,5 TRISPHOSPHATE; KETANSERIN; MESSENGER RNA; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 4 ANTAGONIST; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART ATRIUM; HEART LEFT ATRIUM; HEART PAPILLARY MUSCLE; INOTROPISM; MALE; MUSCLE CONTRACTILITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONIN BLOOD LEVEL;

EID: 0031934537     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701702     Document Type: Article

References (43)

1. BENFEY, B.G., COHEN, J., KUNOS, G. & VERMES-KUNOS, I. (1974). Dissociation of 5-hydroxytryptamine effects on myocardial contractility and cyclic AMP accumulation. Br. J. Pharmacol., 50, 581-585.
2. BÖHM, M., BRÜCKNER, R., HACKBARTH, I., HAUBITZ, B., LINHART, R., MEYER, W., SCHMIDT, B., SCHMITZ, W. & SCHOLZ, H. (1984). Adenosine inhibition of catecholamine-induced increase in force of contraction in guinea pig atrial and ventricular heart preparations. Evidence against a cyclic AMP- and cyclic GMP-dependent effect. J. Pharmacol. Exp. Ther., 230, 483-492.
3. BOESS, F.G. & MARTIN, I.L. (1994). Molecular biology of 5-HT receptors. Neuropharmacology, 3/4, 261-273.
4. BOOZ, G.W. & BAKER, K.M. (1996). Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension, 4, 635-640.
5. BRADFORD, MM. (1976). A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. CELADA, P., MARTIN, F. & ARTIGAS, F. (1994). Effects of chronic treatment with dexfenfluramin on serotonin in rat blood, brain and lung tissue. Life Sci., 15, 1237-1243.
7. DABIRÉ, H., CHAOUCHE-TEYARA, K., CHERQUI, C., FOURNIER, B. & SCHMITT, H. (1992). Pharmacological analysis of the cardiac effects of 5-HT and some 5-HT receptor agonists in the pithed rat. Fund. Clin. Pharmacol., 6, 237-245.
8. DOCHERTY, J.R. (1988). Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 1-8.
9. DU, Y.D., SCHOEMAKER, R.G., BOS, E. & SAXENA, P.R. (1994). Different pharmacological responses of atrium and ventricle: studies with human cardiac tissue. Eur. J. Pharmacol., 259, 173-180.
10. 2 receptor system of the rat tail artery. Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 359-366.
11. FOGUET, M., HOYER, D., PARDO, L.A., PAREKH, A., KLUXEN, F.W., KALKMAN, H.O., STÜHMER, W. & LÜBBERT, H. (1992). Cloning and functional characterization of the rat stomach fundus receptor. EMBO. J., 11, 3481-3487.
12. 4 receptor antagonist. Br. J. Pharmacol., 113, 120P.
13. 4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO. J., 12, 2806-2815.
14. GÖTHERT, M., SCHLICKER, E. & KOLLECKER, P. (1986). Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenalin release in the rat vena cava and in the heart of the pithed rat. Naunyn-Schmiedeberg's. Arch. Pharmacol., 322, 124 130.
15. HAJOS, M., SVENNSON, K., NISSBRANDT, H., OBAL, F.J.R. & CARLSSON, A. (1986). Effects of capsaicin on central monoaminergic mechanisms in the rat. J. Neural. Transm., 66, 221-242.
16. HIGGINS, T.J.C., BAILEY, P.J. & ALLSOPP, D. (1980). Mechanism of stimulation of cardiac myocyte heating rate by 5-hydroxytryptamine. Life Sci., 28, 999-1005.
17. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). IUPHAR classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
18. JAHNEL, U., RUPP, J., ERTL, R. & NAWRATH, H. (1992). Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn-Schmiedeberg's. Arch. Pharmacol., 346, 482-485.
19. 1C receptor. Science, 241, 558-564.
20. 4-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 619-622.
21. 4-like receptors in mammalian atria. J. Neural. Transm., 34, 195-201.
22. 4 receptors mediate arrhythmias? Trends Pharmacol. Sci., 15, 451-455.
23. 4-like receptors in piglet left atrium. Br. J. Pharmacol., 102, 98P.
24. 4 receptor population in piglet right atrium: functional relevance. Br. J. Pharmacol., 115, 933 936.
25. 4-like receptor in human left atrium. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 382 386.
26. 4 receptors in human atrium: facilitation by chronic β-adrenoceptor blockade. Naunyn-Schmiedeberg's Arch. Pharmacol., 349, 331-337.
27. KAUMANN, A.J., SANDERS, L., BROWN, A.M., MURRAY, K.J. & BROWN, M.J. (1990). A 5-hydroxytryptamine receptor in human atrium. Br. J. Pharmacol., 100, 879-885.
28. 2 antagonist, on the pressor and tachycardiac responses to 5-hydroxytryptamine in rats. lugoslav. Physiol. Pharmacol. Acta. 25, (suppl 3), 73-74.
29. 2 receptors. Mol. Pharmacol., 42, 328-335.
30. 2 and affinity constants for pharmacological competitive antagonists be estimated? J. Pharm. Pharmacol., 30, 312-313.
31. 3 receptor, a serotonin-gated ion channel. Science. 254, 432-437.
32. MAYR, G.W. & THIELECZEK, R. (1991). Masses of inositol phosphates in resting and tetanically stimulated vertebrate skeletal muscles. Biochem. J., 280, 631-640.
33. MOLENAAR, P. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ. Res., 72, 526-538.
34. 4 receptors. Mol. Pharmacol., 41, 346-351.
35. PARKER, S.G. (1995). Blockade of human and porcine myocardial 5-HT4 receptors by SB 203186. Naunyn Schmiedeberg's Arch. Pharmacol., 353, 28-35.
36. PAZOS, A., CORTES, R. & PALACIOSA, J.M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. Brain Res., 346, 231-249.
37. 3 antagonists on 5-hydroxytryptamine-evoked release of calcitonin gene-related peptide in the guineapig heart. Br. J. Pharmacol., 108, 431-435.
38. TRENDELENBURG, U. (1960). The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J. Pharmacol. Exp. Ther., 130, 450-460.
39. ULLMER, C., SCHMUCK, K., KALKMAN, H.O. & LÜBBERT, H. (1995). Expression of serotonin receptor mRNAs in blood vessels. FEBS Letts., 370, 215-221.
40. 2 serotonergic receptors. J. Pharmacol. Exp. Ther., 218, 217-230.
41. VERBEUREN, T.J. (1992). In 5-Hydroxytryptamine: Distribution, Synthesis, Metabolism, Release, Uptake, and Passage Across Body Membranes in Cardiovascular Tissues Including Blood-Brain Barrier. ed. Olesen J. & Saxena P.R. New York: Raven Press Ltd.
42. 4 receptor. Br. J. Pharmacol., 102, 107-112.
43. 2F receptor. Mol. Pharmacol., 42, 419-426.